Featured Organizations and Speakers
Attend the DIA 2022 Global Annual Meeting to collaborate and get the latest directly from representatives of national regulators, HTA bodies, patient advocacy groups, and other critical stakeholders. Get to know some of the organizations that will be part of the largest global life sciences event of the year.
- Meet the Keynote Speakers
- Meeting Speakers from Austrian Agency for Health and Food Safety
- Meeting Speakers from ANVISA
- Meeting Speakers from the Central Drugs Standard Control Organization
- Meeting Speakers from the European Medicines Agency
- Meeting Speakers from the European Commission
- Meeting Speakers from the US FDA
- Meeting Speakers from Health Canada
- Meeting Speakers from the INFARMED
- Meeting Speakers from the Medicines and Healthcare products Regulatory Agency
- Meeting Speakers from the National Agency for Food and Drug Administration and Control
- Meeting Speakers from the National Medical Products Administration (NMPA)
- Meeting Speakers from the Norwegian Medicines Agency
- Meeting Speakers from the Oak Ridge Institute For Science and Education
- Meeting Speakers from Paul-Ehrlich-Institut
- Meeting Speakers from the Pharmaceuticals and Medical Devices Agency (PMDA)
- Meeting Speakers from Swissmedic
- Featured Organizations
-
Meet the Keynote Speakers
DIA is Proud to Announce the DIA 2022 Global Annual Meeting Keynote Speakers who will Speak on the Future of Healthcare
As we emerge from the SARS-CoV-2 pandemic, the importance of inspiration and seeing a future where all people have access to lifesaving interventions has never been greater, and DIA aims to highlight some of the most forward-looking and positive views of what the future of healthcare will be. This year’s format will be presented as a series of perspectives representing diversity of thinking, topic, and geography, to include:
Miruna Sasu, President and Chief Executive Officer, COTA
The Future of Healthcare is Inclusive
Overcoming barriers to access globally requires information sharing, trusted communication, and increased awareness of regulatory science challenges. Collaboration and coordination, as demonstrated by medicines regulatory authorities in times of crisis, can enhance global reliance and cooperation to increase efficiency and bring solutions to the patients that need them.
Emer Cooke, Chair International Coalition of Medicines Regulatory Authorities (ICMRA)
The Future of Healthcare is Global
Overcoming barriers to access globally requires information sharing, trusted communication, and increased awareness of regulatory science challenges. Collaboration and coordination, as demonstrated by medicines regulatory authorities in times of crisis, can enhance global reliance and cooperation to increase efficiency and bring solutions to the patients that need them.
Ken Getz, Director Center for the Study of Drug Development at Tufts University
The Future of Healthcare is Centered on the Individual Patient
Patients have always been at the center of their care but there is growing need and acceptance in clinical R&D that patients are stakeholders in clinical decision making, health IT user experience, and medical product development. Focusing on what matters to patients and gathering feedback through the clinical development pipeline is an important element of improving study quality and ultimately impacting accessibility, perceptions, and market penetration. Patient preferences and satisfaction also serve as indicators for continuous improvement that can drive retention and operational efficiency.
Andre Asbury, Manager, Chicago Lighthouse Tools for Living Retail Store
The Future of Healthcare is Digital – A Patient Perspective
Andre Asbury is a Retail Sales Lead at The Chicago Lighthouse’s Tools for Living Store. In his role he meets with blind and visually impaired customers to answer questions about the newest innovations in assistive technology and independent living aids. In addition, Andre is an experienced user of wearable technology at home and in the workplace.
Speakers
-
Barbara Lopez Kunz, MBA, MS, MSc
- Director | Advisor | CEO
- United States
Barbara Lopez Kunz served as President and Global Chief Executive of DIA, driving thought leadership and innovation in therapeutic development to improve the health of people worldwide. She previously served as President of Health and Life Sciences at Battelle, one of the world’s largest, most respected R&D organizations. She has also served as Senior Vice President/General Manager for Thermo Fisher Scientific’s Biosciences Division, as SVP for DuPont, and head of R&D for ICI. A dedicated volunteer for children's health, Barbara chairs the board of Children's National Research Institute, serves as advisor to the UC I4H Fellowship, and as Director for Aptevo Therapeutics.